These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement. Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388 [TBL] [Abstract][Full Text] [Related]
15. Systemic light-chain amyloidosis presenting with rapid progressive heart failure. Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674 [TBL] [Abstract][Full Text] [Related]
16. [Amyloidosis is a rare cause of heart failure]. Delekta J; Mrgan M Ugeskr Laeger; 2015 Jan; 177(2A):126-7. PubMed ID: 25613002 [TBL] [Abstract][Full Text] [Related]
17. Resolution of heart failure in patients with AL amyloidosis. Dubrey S; Mendes L; Skinner M; Falk RH Ann Intern Med; 1996 Sep; 125(6):481-4. PubMed ID: 8779461 [TBL] [Abstract][Full Text] [Related]
18. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis. Schattner A; Epstein M; Berrebi A; Caspi A Am J Med Sci; 1995 Dec; 310(6):256-7. PubMed ID: 7503107 [TBL] [Abstract][Full Text] [Related]
19. [Primary amyloidosis associated with multiple myeloma and renal failure: case report]. Peña O C; Intriago B M; Gray H AM; Cabrera C ME Rev Med Chil; 2011 Nov; 139(11):1471-4. PubMed ID: 22446653 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis. Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]